NASDAQ:CASI   CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc (NASDAQ:CASI) The daily chart is shaping up and I expect the next point of resistance to be at $2.25. At some point CASI will take off and never look back. I think that day will come soon and those buying at these prices will be thanking me down the road. Oppenheimer analyst Leland Gershell recently raised the price target on CASI to $6.00 (from $5.00) while maintaining Outperform rating and the CEO purchased 480000 shares in August owning more than 5 million shares. I think CASI is heading higher from here and will make an excellent trade going forward.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.